Workflow
BNP Paribas Primary New Issues: STAB Notice - No Stab CMA
STATERA BIOPHARMSTATERA BIOPHARM(US:STAB) GlobeNewswire News Room·2025-07-01 08:20

Group 1 - The issuer of the securities is CMA CGM S.A, with an aggregate nominal amount of EUR 600 million [3] - The securities have a fixed interest rate of 5% and are due in January 2031 [3] - The offer price for the securities is set at 100 [3] Group 2 - No stabilisation activities were carried out in relation to the offer of the securities [2] - The stabilisation managers involved include HSBC, ING, SG, BRED, CIC, CITI, NTX, and SANTANDER [4] - The announcement clarifies that the securities are not offered for sale in the United States and have not been registered under the U.S. Securities Act of 1933 [5]